Why Amgen thinks Celgene's psoriasis drug is worth $ 13.4 billion



[ad_1]

Aug. 26 – Amgen Inc. to pay $ 13.4 billion to purchase flagship psoriasis drug at Celgene Corp. Kailey Leinz talks about "Balance of Power".

[ad_2]
Source link